X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.globenewswire.com/news-release/2022/08/22/2502147/0/en/Cue-Biopharma-Doses-First-Patient-in-Phase-1-Study-of-CUE-102-for-Wilms-Tumor-1-WT1-expressing-cancers.html
https://www.businesswire.com/news/home/20210908006073/en/Calypso-Biotech-Announces-First-Patient-With-Celiac-Disease-Dosed-in-anti-Interleukin-15-IL-15-Monoclonal-Antibody-CALY-002-Phase-1b-Trial-and-Extension-of-Series-A-to-%E2%82%AC28M
https://www.globenewswire.com/news-release/2021/09/08/2293345/0/en/Selecta-Biosciences-and-Cyrus-Biotechnology-Enter-Collaboration-to-Create-Novel-Engineered-Therapeutic-Proteins.html
https://www.biospace.com/article/releases/synthekine-launches-with-82-million-series-a-financing-to-advance-pipeline-of-engineered-cytokine-therapeutics-optimized-for-cancer-and-autoimmune-diseases/?s=80
https://endpts.com/eli-lillys-1-6b-cancer-drug-failed-to-spark-even-the-slightest-positive-gain-for-patients-in-its-1st-phiii/
https://www.businesswire.com/news/home/20191210005715/en/LEO-Pharma-announces-positive-top-line-results-tralokinumab/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://www.fiercebiotech.com/biotech/lilly-s-armo-buyout-drug-a-bust-pancreatic-cancer
https://www.biospace.com/article/lilly-s-pancreatic-drug-flunks-phase-iii-trial/?s=95
https://www.businesswire.com/news/home/20191015005305/en/CEL-SCI-Reports-Data-Review-Independent-Data-Monitoring/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.fiercebiotech.com/research/treating-glioblastoma-il-12-gene-therapy-drug-switch-combination
https://endpts.com/after-playing-possum-in-i-o-eli-lilly-shows-new-signs-of-life-with-40m-plus-cash-discovery-deal-for-nextcure/
https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-sanofi-s-chengdu-r-d-hub-takeda-s-osaka-hq-sale-i-mab-s-220m-financing
https://www.fiercebiotech.com/i-mab-closes-one-china-s-biggest-ever-biotech-fundraisings
https://www.fiercebiotech.com/shkreli-stocks-still-sharing-biotech-tips
https://www.biospectrumasia.com/news/26/11148/cell-in-a-box-encapsulated-cells-to-produce-interleukin-2-.html
https://www.bloomberg.com/news/articles/2018-06-01/next-generation-therapies-in-focus-at-year-s-top-cancer-meeting
https://www.prnewswire.com/news-releases/i-mab-biopharma-signs-licensing-agreement-for-hyleukin-with-genexine-300575221.html
https://www.pharmacompass.com/pdf/news/united-therapeutics-unituxin-dinutuximab-approved-in-eu-for-neuroblastoma-1441193180.pdf
Market Place
Share 
